Cetylpyridinium chloride: Difference between revisions
Rabin Bista (talk | contribs) No edit summary |
Rabin Bista (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{DrugProjectFormSinglePage | {{DrugProjectFormSinglePage | ||
|authorTag={{RB}} | |authorTag={{RB}} | ||
|OTC=Yes | |OTC=Yes | ||
|genericName=Cetylpyridinium chloride | |genericName=Cetylpyridinium chloride | ||
Line 44: | Line 44: | ||
<!--Contraindications--> | <!--Contraindications--> | ||
|contraindications= | |contraindications=<!--Warnings--> | ||
<!--Warnings--> | |||
|warnings=Keep out of reach of children under 6 years of age. | |warnings=Keep out of reach of children under 6 years of age. | ||
Line 128: | Line 126: | ||
<!--Postmarketing Experience--> | <!--Postmarketing Experience--> | ||
|postmarketing=staining of the teeth and tongue | |postmarketing=staining of the teeth and tongue | ||
|drugInteractions= | |drugInteractions=<!--Use in Specific Populations--> | ||
<!--Use in Specific Populations--> | |||
|useInPregnancyFDA=* '''Pregnancy Category''' | |useInPregnancyFDA=* '''Pregnancy Category''' | ||
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | |useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | ||
Line 148: | Line 144: | ||
<!--Administration and Monitoring--> | <!--Administration and Monitoring--> | ||
|administration=* Oral | |administration=* Oral | ||
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | |monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | ||
Line 163: | Line 157: | ||
<!--Drug box 2--> | <!--Drug box 2--> | ||
|drugBox=<!--Mechanism of Action--> | |drugBox={{chembox2 | ||
| verifiedrevid = 477000351 | |||
| ImageFile = Cetylp Wiki str.png | |||
| ImageSize = | |||
| IUPACName = 1-Hexadecylpyridinium chloride | |||
| OtherNames = Acetoquat CPC; <br>Pyrisept | |||
EXADECYL-PYRIDINIUM, CHLORIDE | |||
| Section1 = {{Chembox Identifiers | |||
| Beilstein = 3578606 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 28979 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 6BR7T22E2S | |||
| InChI = 1/C21H38N.ClH/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-22-20-17-15-18-21-22;/h15,17-18,20-21H,2-14,16,19H2,1H3;1H/q+1;/p-1 | |||
| InChIKey = YMKDRGPMQRFJGP-REWHXWOFAU | |||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | |||
| ChEMBL = 34833 | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C21H38N.ClH/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-22-20-17-15-18-21-22;/h15,17-18,20-21H,2-14,16,19H2,1H3;1H/q+1;/p-1 | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = YMKDRGPMQRFJGP-UHFFFAOYSA-M | |||
| CASNo_Ref = {{cascite|correct|CAS}} | |||
| CASNo = 123-03-5 | |||
| CASNo1 = 6004-24-6 | |||
| CASNo1_Comment = (monohydrate) | |||
| ATCCode_prefix = B05 | |||
| ATCCode_suffix = CA01 | |||
| ATC_Supplemental = {{ATC|D08|AJ03}},<br />{{ATC|D09|AA07}} (dressing), {{ATC|R02|AA06}} | |||
| PubChem = 31239 | |||
| ChEBI_Ref = {{ebicite|correct|EBI}} | |||
| ChEBI = 32915 | |||
| SMILES = [Cl-].[n+]1(ccccc1)CCCCCCCCCCCCCCCC | |||
}} | |||
<!--Mechanism of Action--> | |||
|mechAction=* | |mechAction=* | ||
Revision as of 13:15, 21 April 2015
{{DrugProjectFormSinglePage |authorTag=Rabin Bista, M.B.B.S. [1] |OTC=Yes |genericName=Cetylpyridinium chloride |aOrAn=a |drugClass=antiseptic |indicationType=treatment |indication=gingivitis |adverseReactions=staining of the teeth and tongue
|blackBoxWarningTitle=ConditionName: |blackBoxWarningBody=ConditionName:
- Content
|fdaLIADAdult=====Indications====
helps control plaque that leads to gingivitis
Dosage
|offLabelAdultGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Cetylpyridinium chloride in adult patients.
|offLabelAdultNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Cetylpyridinium chloride in adult patients.
|fdaLIADPed=====Indications====
helps control plaque that leads to gingivitis
Dosage
|offLabelPedGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Cetylpyridinium chloride in pediatric patients.
|offLabelPedNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Cetylpyridinium chloride in pediatric patients.
|contraindications= |warnings=Keep out of reach of children under 6 years of age.
If more than used for rinsing is accidentally swallowed, get medical help or contact a Poison Control Center right away.
Stop use and ask a dentist if
gingivitis, bleeding, or redness persists for more than 2 weeks you have painful or swollen gums, pus from the gum line, loose teeth, or increasing spacing between the teeth These may be signs or symptoms of periodontitis, a serious form of gum disease.
|clinicalTrials=There is limited information regarding Clinical Trial Experience of Cetylpyridinium chloride in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
|postmarketing=staining of the teeth and tongue |drugInteractions= |useInPregnancyFDA=* Pregnancy Category |useInPregnancyAUS=* Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Cetylpyridinium chloride in women who are pregnant. |useInLaborDelivery=There is no FDA guidance on use of Cetylpyridinium chloride during labor and delivery. |useInNursing=There is no FDA guidance on the use of Cetylpyridinium chloride with respect to nursing mothers. |useInPed=There is no FDA guidance on the use of Cetylpyridinium chloride with respect to pediatric patients. |useInGeri=There is no FDA guidance on the use of Cetylpyridinium chloride with respect to geriatric patients. |useInGender=There is no FDA guidance on the use of Cetylpyridinium chloride with respect to specific gender populations. |useInRace=There is no FDA guidance on the use of Cetylpyridinium chloride with respect to specific racial populations. |useInRenalImpair=There is no FDA guidance on the use of Cetylpyridinium chloride in patients with renal impairment. |useInHepaticImpair=There is no FDA guidance on the use of Cetylpyridinium chloride in patients with hepatic impairment. |useInReproPotential=There is no FDA guidance on the use of Cetylpyridinium chloride in women of reproductive potentials and males. |useInImmunocomp=There is no FDA guidance one the use of Cetylpyridinium chloride in patients who are immunocompromised.
|administration=* Oral |monitoring=There is limited information regarding Monitoring of Cetylpyridinium chloride in the drug label.
|IVCompat=There is limited information regarding IV Compatibility of Cetylpyridinium chloride in the drug label.
|overdose=There is limited information regarding Overdose of Cetylpyridinium chloride in the drug label.
|drugBox=
Template:Chembox header2 | Cetylpyridinium chloride | |
---|---|
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
PubChem CID
|
|
UNII | |
| |
| |
Template:Chembox header2 | Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
{{#subobject:
|Page Name=Cetylpyridinium chloride |Pill Name=No image.jpg |Drug Name= |Pill Ingred=|+sep=; |Pill Imprint= |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}} |Pill Color=|+sep=; |Pill Shape= |Pill Size (mm)= |Pill Scoring= |Pill Image= |Drug Author= |NDC=
}}
{{#subobject:
|Label Page=Cetylpyridinium chloride |Label Name=Cetylpyridinium chloride11.png
}}
{{#subobject:
|Label Page=Cetylpyridinium chloride |Label Name=Cetylpyridinium chloride11.png
}}